No results for ‘’
Aarey Drugs & Pharmaceuticals Ltd
₹102.75
(0.22%)
Sat, 26 Sept 2026, 04:38 am
Health Technology
Pharmaceuticals: Major
24.5KAarey Drugs & Pharmaceuticals Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 37.71 | 39.05 | 44.80 | 44.80 | 44.80 |
| FII | 4.18 | 3.86 | 1.13 | 1.97 | 2.34 |
| DII | 1.62 | 0 | 0 | 0 | 0 |
| Public | 56.49 | 57.09 | 54.07 | 53.23 | 52.86 |
| Government | 0 | 0 | 0 | 0 | 0 |
Aarey Drugs & Pharmaceuticals Ltd Shareholding Pattern
The Aarey Drugs & Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Aarey Drugs & Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Aarey Drugs & Pharmaceuticals Ltd (NSE: AAREYDRUGS, BSE: 524412) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Aarey Drugs & Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Aarey Drugs & Pharmaceuticals Ltd Shareholding Pattern (Latest)
The latest Aarey Drugs & Pharmaceuticals Ltd shareholding for Mar 2026 is:
- Promoters: 37.71%
- FII: 4.18%
- DII: 1.62%
- Public: 56.49%
- Government: 0%
A slight decline in promoter holding may indicate stake dilution or strategic selling.
Aarey Drugs & Pharmaceuticals Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Aarey Drugs & Pharmaceuticals Ltd.
- Mar 2026: 37.71%
- Dec 2025: 39.05%
- Sept 2025: 44.80%
- Jun 2025: 44.80%
- Mar 2025: 44.80%
Promoter stake remains largely stable, showing consistent ownership structure.
Aarey Drugs & Pharmaceuticals Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Aarey Drugs & Pharmaceuticals Ltd.
- Mar 2026: 4.18%
- Dec 2025: 3.86%
- Sept 2025: 1.13%
- Jun 2025: 1.97%
- Mar 2025: 2.34%
FII holding in Aarey Drugs & Pharmaceuticals Ltd has increased recently, indicating rising foreign investor interest.
Aarey Drugs & Pharmaceuticals Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 1.62%
- Dec 2025: 0%
- Sept 2025: 0%
- Jun 2025: 0%
- Mar 2025: 0%
DII stake in Aarey Drugs & Pharmaceuticals Ltd has increased over time, indicating growing domestic institutional confidence.
Aarey Drugs & Pharmaceuticals Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 56.49%
- Dec 2025: 57.09%
- Sept 2025: 54.07%
- Jun 2025: 53.23%
- Mar 2025: 52.86%
Public holding remains stable with consistent retail participation.
Aarey Drugs & Pharmaceuticals Ltd Government Holding
Government holding in Aarey Drugs & Pharmaceuticals Ltd currently stands at 0%.
Aarey Drugs & Pharmaceuticals Ltd operates without significant government ownership.
Aarey Drugs & Pharmaceuticals Ltd Shareholding Analysis Summary
The Aarey Drugs & Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Aarey Drugs & Pharmaceuticals Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Aarey Drugs & Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.